A Machine Learning Approach to Determine Risk Factors for Respiratory Bacterial/Fungal Coinfection in Critically Ill Patients with Influenza and SARS-CoV-2 Infection: A Spanish Perspective.
Saved in:
| Title: | A Machine Learning Approach to Determine Risk Factors for Respiratory Bacterial/Fungal Coinfection in Critically Ill Patients with Influenza and SARS-CoV-2 Infection: A Spanish Perspective. |
|---|---|
| Authors: | Rodríguez A; Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.; Faculty of Medicine, Universitat Rovira & Virgili, 43005 Tarragona, Spain.; Pere Virgili Health Research Institute, 43005 Tarragona, Spain.; Centre for Biomedical Research Network Respiratory Diseases (CIBERES), 43005 Tarragona, Spain., Gómez J; Faculty of Medicine, Universitat Rovira & Virgili, 43005 Tarragona, Spain.; Technical Secretary's Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain., Martín-Loeches I; Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St James' Hospita, D08 NHY1 Dublin, Ireland., Claverias L; Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.; Pere Virgili Health Research Institute, 43005 Tarragona, Spain., Díaz E; Critical Care Department, Hospital Universitari Parc Tauli, 08208 Sabadell, Spain.; Medicine Faculty, Universitat Autónoma de Barcelona, 08193 Sabadell, Spain., Zaragoza R; Critical Care Department, Hospital Dr. Peset, 46017 Valencia, Spain., Borges-Sa M; Critical Care Department, Hospital Son Llatzer, 07198 Palma de Mallorca, Spain., Gómez-Bertomeu F; Faculty of Medicine, Universitat Rovira & Virgili, 43005 Tarragona, Spain.; Pere Virgili Health Research Institute, 43005 Tarragona, Spain.; Microbiology/Clinical Analysis Laboratory, Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain.; Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), 28220 Madrid, Spain., Franquet Á; Faculty of Medicine, Universitat Rovira & Virgili, 43005 Tarragona, Spain.; Technical Secretary's Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain., Trefler S; Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.; Pere Virgili Health Research Institute, 43005 Tarragona, Spain., González Garzón C; Postgrado Medicina Crítica y Cuidado Intensivo, Facultad de Medicina, Fundación Universitari Ciencias de la Salud, Distrito Especial, Cra. 54 No.67A-80, Bogotá 111221, Colombia., Cortés L; Postgrado Medicina Crítica y Cuidado Intensivo, Facultad de Medicina, Fundación Universitari Ciencias de la Salud, Distrito Especial, Cra. 54 No.67A-80, Bogotá 111221, Colombia., Alés F; Internal Medicine Department, Hospital Dr. Alejandro Gutiérrez, Venado Tuerto S2600, Argentina., Sancho S; Critical Care Department, Hospital Universitrio y Politécnico La Fe, 46026 Valencia, Spain., Solé-Violán J; Critical Care Department, Hospital Dr. Negrin, 35010 Las Palmas de Gran Canaria, Spain., Estella Á; Critical Care Department, University Hospital of Jerez, INIBiCA, 11407 Jerez, Spain.; Faculty of Medicine, University of Cádiz, 11407 Jerez, Spain., Berrueta J; Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.; Tarragona Health Data Research Working Group (THeDaR), 43005 Tarragona, Spain., García-Martínez A; Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.; Tarragona Health Data Research Working Group (THeDaR), 43005 Tarragona, Spain., Suberviola B; Critical Care Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain., Guardiola JJ; Robley Rex VA Medical Center, University of Louisville, Louisville, KY 40202, USA., Bodí M; Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.; Faculty of Medicine, Universitat Rovira & Virgili, 43005 Tarragona, Spain.; Pere Virgili Health Research Institute, 43005 Tarragona, Spain. |
| Corporate Authors: | GETGAG/COVID-19 SEMICYUC Working Group |
| Source: | Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2024 Oct 14; Vol. 13 (10). Date of Electronic Publication: 2024 Oct 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101637404 Publication Model: Electronic Cited Medium: Print ISSN: 2079-6382 (Print) Linking ISSN: 20796382 NLM ISO Abbreviation: Antibiotics (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2079-6382 |
|---|---|
| DOI: | 10.3390/antibiotics13100968 |
